Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 602 07 850.4 |
96 | EP file number | EAKZ | 02 74 8367.6 |
86 | WO file number | WAKZ | PCT/US02/06184 |
97 | EP publication number | EPN | 1389207 |
87 | WO publication number | WPN | 2002070518 |
54 | Designation/title | TI | POLYMORPHE UND ANDERE KRISTALLINE FORMEN VON CIS-FTC |
51 | IPC main class | ICM (ICMV) | C07D 411/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/506 (2006.01), A61P 31/18 (2006.01) |
22 | DE application date | DAT | Mar 1, 2002 |
96 | EP application date | EAT | Mar 1, 2002 |
86 | WO application date | WAT | Mar 1, 2002 |
43 | Date of first publication | OT | Sep 12, 2002 |
| Date of publication of grant | PET | Dec 7, 2005 |
71/73 | Applicant/owner | INH | Abbott Laboratories, Abbott Park, Ill., US; Gilead Sciences, Inc., 94404 Foster City, Calif., US |
72 | Inventor | IN | PHARES R., Kenneth, Chapel Hill, US; LAW, Devalina, Libertyville, US; HU, Yuerong, Lafayette, US |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000060207850T2 Searchable text:
DE000060207850T2 |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 272560 P Mar 1, 2001
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 309605 P Aug 2, 2001
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001389207 Searchable text:
EP000001389207 Original document:
EP000001389207B1 Searchable text:
EP000001389207B1 Original document:
WO002002070518 Searchable text:
WO002002070518 |
43 | Date of first publication | EVT | Sep 12, 2002 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025 (Show all update days)(Hide all update days)- Jan 5, 2025
- St.36: changed (technical change)
- Dec 24, 2019; Nov 19, 2019; Aug 21, 2019; Apr 10, 2019; Oct 29, 2018; Mar 17, 2018; Apr 11, 2017; Mar 2, 2017; Feb 28, 2017; Mar 1, 2016; Oct 23, 2015; Mar 7, 2015; Apr 29, 2014; Apr 9, 2014; Apr 10, 2013; Mar 14, 2013; Jan 26, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 3, 2005 |
71/73 | Applicant/owner | INH | Abbott Laboratories, Abbott Park, Ill., US; Gilead Sciences, Inc., 94404 Foster City, Calif., US |
71/73 | Previous applicant/owner | INHF | Triangle Pharmaceuticals Inc., Durham, N.C., US, Abbott Laboratories, Abbott Park, Ill., US |